Identification of DNA methylation biomarkers in amniotic fluid for prenatal detection of congenital heart disease (CHD)

Weilun Zuo(Fujian Women and Children Hospital), Huiming Ye(Xiamen University), Xiaoqin He(Children’s Hospital of Fudan University Xiamen Branch), Han Yang(Fujian Women and Children Hospital), Jianwei Rao(Xiamen University), Jiali Cao(Fujian Women and Children Hospital), Yaqin Ma(Fujian Women and Children Hospital), Shiyu Sun(Xiamen University)
Clinical Epigenetics
February 26, 2026
10.1186/s13148-026-02090-4
Cited by 0

Related Papers

Identification of Key Factors in Cartilage Tissue During the Progression of Osteoarthritis Using a Non-targeted Metabolomics Strategy
|Phenomics|2024|10
Genomic insights into prenatal diagnosis of congenital heart defects: value of CNV-seq and WES in clinical practice
|Frontiers in Genetics|2024|9
An improved multi-objective genetic algorithm and data fusion in structural damage identification
|International Journal of Security and Networks|2019|6
Diagnostic value of karyotyping, CMA/CNV-seq, and WES in fetuses with thickened nuchal translucency: perinatal and two-year follow-up outcomes
|BMC Medical Genomics|2026|0
Additional file 4 of Identification of DNA methylation biomarkers in amniotic fluid for prenatal detection of congenital heart disease (CHD)
|Figshare|2026|0